The development of narrowly-focused vaccines, such as the mRNA vaccines and the adenovector DNA vaccine, could create an evolutionary pressure that leads to the emergence of new virus variants that may no longer be effectively tackled by the vaccine. This was witnessed with break bone fever, a second case of dengue that can utilize the immune response from the first exposure to attack the body in new ways.